# FDA Inspection 1013712 - Fresenius Kabi Oncology Ltd - May 24, 2017

Source: https://www.keypedia.com/records/fda_inspections/fresenius-kabi-oncology-ltd/d569f1f7-caae-429c-9a4e-d98d64f869b0
Source feed: FDA_Inspections

> FDA Inspection 1013712 for Fresenius Kabi Oncology Ltd on May 24, 2017. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1013712
- Company Name: Fresenius Kabi Oncology Ltd
- Inspection Date: 2017-05-24
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 924144 - 2015-03-03](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-oncology-ltd/e6ceb42f-c280-4ff5-be6b-a075e5e17c43)
- [FDA Inspection 815170 - 2013-01-18](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-oncology-ltd/283b6f0d-f1b9-4603-a26a-cfee0923ba0c)
- [FDA Inspection 630128 - 2009-11-06](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-oncology-ltd/5a4064b7-bd2a-49d4-b91d-b5c16c3a8256)

Company: https://www.keypedia.com/companies/fresenius-kabi-oncology-ltd/c145255a-d691-4f05-8873-bf1e09b6aa97

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c